Moelis & Company logo MC - Moelis & Company

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 6
HOLD 12
SELL 4
STRONG
SELL
0
| PRICE TARGET: $73.33 DETAILS
HIGH: $85.00
LOW: $60.00
MEDIAN: $75.00
CONSENSUS: $73.33
UPSIDE: 6.85%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Overvalued Mild
Trading 12.8% above fair value
Current Price $68.63
Bear Case $42.59 37.9% downside ($42.59 - $68.63) / $68.63 = -37.9% ROTCE 20.0% → 1.60x TBV
Fair Value $60.84 11.4% downside ($60.84 - $68.63) / $68.63 = -11.4% ROTCE 25.0% → 2.10x TBV
Bull Case $79.09 15.2% upside ($79.09 - $68.63) / $68.63 = 15.2% ROTCE 30.0% → 2.60x TBV

Adjust Assumptions

41.1%
14.0%

Key Value Driver

ROTCE (41.1%) vs. cost of equity (14.0%)

Implied Market Multiple 8.96x

Plain-Language Summary

With ROTCE of 41.1% vs. 14.0% cost of equity, fair P/TBV is 2.10x on $7.66 tangible book, implying $60.84 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (22 analysts) $73.33
Analyst Range $60.00 – $85.00
Divergence from AlphaVal 17%

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly